Inventor · disambiguated record
Antonio A. Albano
Also filed as: ALBANO ANTONIO · ALBANO ANTONIO A
6 granted patents·6 pending applications·109 citations·filing 1999–2019
81Inventor score
Top patents by PatentIndex Score
12 records- 0189US6350786B1Stable complexes of poorly soluble compounds in ionic polymersHOFFMANN LA ROCHE·Filed 1999·Granted Feb 26, 2002·94 cites·33 claims
- 0284US6486329B1Amorphous form of cell cycle inhibitor having improved solubility and bioavailabilityHOFFMANN LA ROCHE·Filed 2002·Granted Nov 26, 2002·10 cites·4 claims
- 0370US2020330600A1Pharmaceutical compositionHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 0463US6469179B1Amorphous form of cell cycle inhibitor having improved solubility and bioavailabilityHOFFMANN LA ROCHE·Filed 2002·Granted Oct 22, 2002·2 cites·2 claims
- 0562US6482847B2Amorphous form of cell cycle inhibitor having improved solubility and bioavailabilityHOFFMANN LA ROCHE·Filed 2001·Granted Nov 19, 2002·1 cites·9 claims
- 0658US2009054481A1Saquinavir Mesylate Oral Dosage FormALBANO ANTONIO A·Filed 2008·Application pending·0 cites
- 0754US2018369388A1Pharmaceutical compositionHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 0853US6469180B1Amorphous form of cell inhibitor having improved solubility and bioavailabilityHOFFMANN LA ROCHE·Filed 2002·Granted Oct 22, 2002·0 cites·3 claims
- 0953US2013172375A1Pharmaceutical compositionHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 1052US2005009811A1Saquinavir mesylate oral dosage formFiled 2004·Application pending·0 cites
- 1145US2008107725A1Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble PolymersALBANO ANTONIO A·Filed 2007·Application pending·0 cites
- 1239US6492530B1Amorphous form of cell cycle inhibitor having improved solubility and bioavailabilityHOFFMANN LA ROCHE·Filed 2002·Granted Dec 10, 2002·2 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Antonio A. Albano files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →